SGI-1776-VHL-02
Based on 1 Customer Validation
SGI-1776-VHL-02 is a stereoselective PIM PROTAC degrader. SGI-1776-VHL-02 promotes the ubiquitination and degradation of PIM1, PIM2 and PIM3. SGI-1776-VHL-02 downregulates c-myc protein levels, induces Apoptosis. SGI-1776-VHL-02 has anti-cancer activity against prostate cancer. SGI-1776-VHL-02 can be used in studies related to prostate cancer.
(Pink: Pim ligand (HY-13287); Blue: VHL ligand (HY-112078); Black: linker (HY-W015300)).
For research use only. We do not sell to patients.
- Purity : 96.67%
- CAS No.: 3013618-84-0
- Formula: C50H62F3N9O6S
- Molecular Weight:974.14
-
Storage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
All PROTACs Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
PIM1 |
PIM2 |
PIM3 |
In Vitro
SGI-1776-VHL-02 (0.75-10 μM; 24 h) dose-dependently degrades doxycycline-induced PIM1 in PC3-dox-PIM1 cells, with the effective degradation starting at a concentration of 0.75 μM[1].
SGI-1776-VHL-02 (0.75-10 μM; 24 h) stereoselectively degrades doxycycline-induced PIM1 in PC3-dox-PIM1 cells, whereas its inactive epimer control fails to induce such degradation[1].
SGI-1776-VHL-02 (1.5 μM; 24 h) does not alter the level of PIM1 mRNA in PC3 cells, confirming that its effect on PIM1 is post-transcriptional[1].
SGI-1776-VHL-02 (1.5-3.75 μM; 24 h) degrades all three PIM kinase isoforms in PC3 cells, with PIM3 degraded at 1.5 μM and PIM2 degraded at 3.75 μM[1].
SGI-1776-VHL-02 (0.75-6.25 μM; 10 days) inhibits colony formation of prostate cancer cell lines PC3, LNCaP and C4-2[1].
SGI-1776-VHL-02 (3.75 μM; 24 h) downregulates c-myc protein levels in PC3 and LNCaP prostate cancer cells[1].
SGI-1776-VHL-02 (3.75 μM; 4 h) induces apoptosis in PC3 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:PC3, LNCaP, and C4-2 prostate cancer cells
-
Concentration:0.75-6.25 μM
-
Incubation Time:10 days, with media replacement every 96 h
-
Result:Showed a more potent inhibitory effect on colony formation in PC3, LNCaP, and C4-2 cells compared to its parent inhibitor SGI-1776.
Efficiently reduced colony formation at tested concentrations.
-
Cell Line:PC3 and LNCaP prostate cancer cells
-
Concentration:3.75 μM
-
Incubation Time:24 h
-
Result:Downmodulated c-myc after treatment in both PC3 and LNCaP cells.
Showed no c-myc downmodulation effect with the parent inhibitor SGI-1776 or PIM447-VHL-01.
-
Cell Line:PC3 cells
-
Concentration:3.75 μM (SGI-1776-VHL-02); 2 nM (docetaxel)
-
Incubation Time:4 h (SGI-1776-VHL-02 pre-treatment); 48 h (docetaxel incubation)
-
Result:Increased apoptosis significantly to 24% of cells as a single agent.
Increased the percentage of apoptotic cells significantly to 40% when co-treated with docetaxel, which was greater than the combination of docetaxel and SGI-1776.
Chemical Information
-
CAS No. 3013618-84-0
-
Appearance Solid
-
Molecular Weight 974.14
-
Formula C50H62F3N9O6S
-
Color White to off-white
-
SMILES
O=C(N1[C@@H](C[C@H](C1)O)C(N[C@H](C2=CC=C(C3=C(N=CS3)C)C=C2)C)=O)[C@H](C(C)(C)C)NC(CCCCCCC(N(CC4)CCC4CNC5=NN6C(C7=CC(OC(F)(F)F)=CC=C7)=CN=C6C=C5)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (102.65 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
-
Data Sheet (273 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.0265 mL | 5.1327 mL | 10.2655 mL | 25.6637 mL |
| 5 mM | 0.2053 mL | 1.0265 mL | 2.0531 mL | 5.1327 mL | |
| 10 mM | 0.1027 mL | 0.5133 mL | 1.0265 mL | 2.5664 mL | |
| 15 mM | 0.0684 mL | 0.3422 mL | 0.6844 mL | 1.7109 mL | |
| 20 mM | 0.0513 mL | 0.2566 mL | 0.5133 mL | 1.2832 mL | |
| 25 mM | 0.0411 mL | 0.2053 mL | 0.4106 mL | 1.0265 mL | |
| 30 mM | 0.0342 mL | 0.1711 mL | 0.3422 mL | 0.8555 mL | |
| 40 mM | 0.0257 mL | 0.1283 mL | 0.2566 mL | 0.6416 mL | |
| 50 mM | 0.0205 mL | 0.1027 mL | 0.2053 mL | 0.5133 mL | |
| 60 mM | 0.0171 mL | 0.0855 mL | 0.1711 mL | 0.4277 mL | |
| 80 mM | 0.0128 mL | 0.0642 mL | 0.1283 mL | 0.3208 mL | |
| 100 mM | 0.0103 mL | 0.0513 mL | 0.1027 mL | 0.2566 mL |